SCHEMBL4841011

SCHEMBL4841011

COc1ccc(C(=O)/C=C2\NC(C)(C)C(O)c3ccc(OC)cc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.44
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAOB P27338 2/20 0.41
TGM2 P21980 1/20 0.39
KMT2A Q03164 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841025 1.00 HSP90AA1 (0.44) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4839837 0.93 HSP90AA1 (0.39) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4839825 0.93 HSP90AA1 (0.39) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4835389 0.91 KMT2A (0.38) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4844226 0.91 MAOA (0.46) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4844220 0.91 MAOA (0.46) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4835401 0.91 KMT2A (0.38) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4844569 0.78 HSP90AA1 (0.45) HSP90AA1ALDH1A1MAPTNPC1LMNA
SCHEMBL4834518 0.76 ALDH1A1 (0.45) ALDH1A1MAPTNPC1CYP3A4CYP2D6
SCHEMBL4838408 0.76 HSP90AA1 (0.45) HSP90AA1ALDH1A1MAPTNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 HSP90AA1 2527/4885ALDH1A1 2636/4885MAPT 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.